Subthalamic nucleus deep brain stimulation for Parkinson's disease: evidence for effectiveness and limitations from 12 years' experience.

To present the result and experience of subthalamic nucleus deep brain stimulation for Parkinson's disease.
Case series.
Prince of Wales Hospital, Hong Kong.
A cohort of patients with Parkinson's disease received subthalamic nucleus deep brain stimulation from September 1998 to January 2010. Patient assessment data before and after the operation were collected prospectively.
Forty-one patients (21 male and 20 female) with Parkinson's disease underwent bilateral subthalamic nucleus deep brain stimulation and were followed up for a median interval of 12 months. For the whole group, the mean improvements of Unified Parkinson's Disease Rating Scale (UPDRS) parts II and III were 32.5% and 31.5%, respectively (P<0.001). Throughout the years, a multidisciplinary team was gradually built. The deep brain stimulation protocol evolved and was substantiated by updated patient selection criteria and outcome assessment, integrated imaging and neurophysiological targeting, refinement of surgical technique as well as the accumulation of experience in deep brain stimulation programming. Most of the structural improvement occurred before mid-2005. Patients receiving the operation before June 2005 (19 cases) and after (22 cases) were compared; the improvements in UPDRS part III were 13.2% and 55.2%, respectively (P<0.001). There were three operative complications (one lead migration, one cerebral haematoma, and one infection) in the group operated on before 2005. There was no operative mortality.
The functional state of Parkinson's disease patients with motor disabilities refractory to best medical treatment improved significantly after subthalamic nucleus deep brain stimulation. A dedicated multidisciplinary team building, refined protocol for patient selection and assessment, improvement of targeting methods, meticulous surgical technique, and experience in programming are the key factors contributing to the improved outcome.
Authors, Anne Y Y Chan, Jonas H M Yeung, Vincent C T Mok, Vincent H L Ip, Adrian Wong, S H Kuo, Danny T M Chan, X L Zhu, Edith Wong, Claire K Y Lau, Rosanna K M Wong, Venus Tang, Christine Lau, W S Poon
JournalHong Kong medical journal = Xianggang yi xue za zhi / Hong Kong Academy of Medicine (Hong Kong Med J) Vol. 20 Issue 6 Pg. 474-80 (Dec 2014) ISSN: 1024-2708 [Print] China
PMID25345997 (Publication Type: Journal Article)
  • Adult
  • Aged
  • Cohort Studies
  • Deep Brain Stimulation
  • Female
  • Hong Kong
  • Hospitals
  • Humans
  • Male
  • Middle Aged
  • Parkinson Disease (therapy)
  • Postoperative Complications
  • Subthalamic Nucleus (physiology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password:
Type Validation Code Shown: